MSN Group launches India’s First and the most beneficial urinary incontinence drug
Affordable treatment for Overactive Bladder (OAB)–a widely prevalent problem among men and women in India First-line therapy recommended by various international treatment guidelines HYDERABAD, 15th MARCH, 2023 (GPN): MSN Labs, a research-based and fully-integrated global pharmaceutical…








